Aflonac-SP Tablet
Marketer
Panax Matrix Research Laboratory
Salt Composition
Aceclofenac (100mg) + Paracetamol (325mg) + Serratiopeptidase (15mg)
Overview Aflonac-SP Tablet
Combiflam-SP, a dual-action analgesic, targets pain and inflammation in diverse musculoskeletal conditions, including muscle aches, arthritic joint pain, and post-surgical discomfort. Its efficacy extends to inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. Dosage and treatment duration should strictly adhere to your physician's instructions. Administering the medication with food or milk mitigates potential gastrointestinal distress. Consistent, timely intake maximizes therapeutic benefit. Continue treatment as directed by your doctor; premature cessation is discouraged. Potential side effects include nausea, vomiting, abdominal pain, dyspepsia, heartburn, elevated liver enzymes, vertigo, somnolence, and diarrhea. Prolonged therapy necessitates regular monitoring of kidney and liver function, along with blood tests, to detect potential complications. Chronic use carries a risk of serious adverse events such as gastrointestinal bleeding and renal impairment. Combiflam-SP is contraindicated during pregnancy and lactation.
Primary Ingredients of Aflonac-SP Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Aflonac-SP Tablet
Analgesia
Major Benefits of Aflonac-SP Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not crush, chew, or divide it. Consume Aflonac-SP Tablet with a meal.
Common Side effects of Aflonac-SP Tablet:
- Nausea
- Vomiting
- Stomach pain
- Indigestion
- Heartburn
- Loss of appetite
- Diarrhea
- Dizziness
- Increased liver enzymes
- Drowsiness
How to use Aflonac-SP Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Aflonac-SP Tablet with a meal.
How Aflonac-SP Tablet works:
Aflonac-SP tablets contain aceclofenac, paracetamol, and serratiopeptidase, a three-drug formulation. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), and paracetamol, an antipyretic, act synergistically to quell pain and fever by inhibiting the production of specific inflammatory mediators. Serratiopeptidase, a proteolytic enzyme, facilitates healing by degrading excess proteins associated with inflammation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Aflonac-SP Tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Aflonac-SP Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on Aflonac-SP Tablet use while breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Taking Aflonac-SP Tablets might reduce alertness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Aflonac-SP Tablets cautiously, potentially requiring dosage modification under medical supervision. Aflonac-SP Tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Aflonac-SP tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Aflonac-SP tablets are contraindicated for those with severe or active liver disease.
What if you forget to take Aflonac-SP Tablet :
Should you forget a dose of Aflonac-SP Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Aflonac-SP Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Pain Relievers |



